🇺🇸 FDA
Pipeline program

Phlebotomy

PPO-C- 03-006

Phase 3 other completed

Quick answer

Phlebotomy for Hemochromatosis is a Phase 3 program (other) at Atrium Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Atrium Therapeutics
Indication
Hemochromatosis
Phase
Phase 3
Modality
other
Status
completed

Clinical trials